Albumedix: Jonas Skjødt Møller, CEO
Life-sciences company Albumedix has appointed Jonas Skjødt Møller as its new CEO, effective July 1. With the company for eight years, Møller has held a number of positions within the company, including in the laboratories and on the front line with customers.
“The opportunities ahead are game changing, especially today as we witness the need globally for rapidly scalable vaccine platforms and advanced therapies to significantly transform lives,” Møller said. "The vision is to empower excellence: in how we as a business operate and create products and services of the highest quality; but also to enable our customers and partners to excel in the development of transformative therapies, and thereby support life sciences and patients equally.”